CA
NZ
UK
AU
IND
US
Dogwood Therapeutics, Inc. (NASDAQ: DWTX), a development-stage biopharmaceutical company focused on non-opioid pain treatments, announced a net loss of $11.5 million for the second quarter ending June 30, 2026. This loss translates to $0.34 per share, significantly higher than the $3.8 million loss reported …
Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a major player in the pharmaceuticals industry with a marketCapitalizationof approximately $44 million, reported total revenue of $33.4 million for the second quarter of 2026. Investor concerns are mounting as the company grapples with decreases in both total and …
MeiraGTx Holdings plc (NASDAQ: MGTX) has achieved a remarkable turnaround with a net income of $160.7 million for the quarter ending June 30, 2026. This stark contrast comes after reporting a net loss of $38.8 million for the same quarter in 2025. The substantial …
Parabilis Medicines, Inc. (NASDAQ: PBLS), a clinical-stage biopharmaceutical company, reported a strong cash position of $1.1 billion as of June 30, following a successful upsized initial public offering (IPO) that raised $770.5 million. The substantialCapitalincreases the company's financial flexibility to fund its ongoing research …
Pulmatrix, Inc. (NASDAQ: PULM) is a micro‑cap biopharmaceutical firm with aMarket Capitalisationof $6 million, 3,652,285 shares outstanding and $2.2 million in cash and cash equivalents. The company focuses on inhaled therapeutics built on its iSPERSE™ platform and is managing a strategic consolidation with Eos …
The company operates with reported debt of $8.91 million against $9.61 million in cash and equivalents. These figures indicate a relatively stableLiquidityposition. However, Rockwell faces significant challenges as it continues to report declining revenues alongside negative net margins, drawing attention from investors who closely …
The Trump administration's ambitious proposal to unbundle the widely administered measles, mumps, and rubella (MMR) vaccine into three separate doses is encountering substantial pushback from both regulatory bodies and pharmaceutical manufacturers. The potential shift has introduced uncertainty for vaccine developers and public health officials …
Tiny Health has made headlines by securing the 208th spot on the 2026 Inc. 5000 list, marking it as one of America's fastest-growing private companies. This recognition is a testament to its impressive revenue growth of 1,624% from 2022 to 2025, notably outpacing many …
Charlotte's Web Holdings, Inc. (OTC: CWBHF), a leader in botanical wellness products, reported significant improvements for the second quarter of 2026. The company achieved a gross margin of 47.5% and successfully reduced operating cash use to $0.9 million. This marks a notable advancement from …
Cellectar Biosciences, Inc. (NASDAQ: CLRB) trades with aMarket Capitalisationof $21 million and a float of 8,252,108 shares, while holding $33.99 million in cash and equivalents. At the close of the June 30, 2026 quarter the cash balance was reported at $34.0 million, reflecting a …
Please wait processing your request...